Spots Global Cancer Trial Database for Characterization of Human Autoantibody Titers After Central Nervous System Insult

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Characterization of Human Autoantibody Titers After Central Nervous System Insult

Official Title: Characterization of Human Autoantibody Titers After Central Nervous System Insult

Study ID: NCT03089749

Conditions

Brain Injuries, Traumatic

Spinal Cord Trauma

Intracranial Neoplasm

Interventions

Study Description

Brief Summary: The aim of the study is to quantitate Central Nervous System (CNS) autoantibody development in human blood using ELISA after human brain injury, spinal cord injury, and intra-axial brain surgeries.

Detailed Description: Study Objectives: We aim to: 1. Quantitate CNS autoantibody development in human blood using ELISA after human brain injury, spinal cord injury, and intra-axial brain surgeries. We also aim to characterize the temporal course of this response. 2. Characterize how CNS autoantibody levels correlate with specific injury patterns as well as radiographic and clinical measures of injury severity. 3. Determine how intercurrent infection and a history of prior CNS insult affects the temporal course and magnitude of autoantibody production.